Clinical implications of the melatonin phase response curve
- PMID: 20610608
- PMCID: PMC2928905
- DOI: 10.1210/jc.2010-1031
Clinical implications of the melatonin phase response curve
Comment on
-
Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg.J Clin Endocrinol Metab. 2010 Jul;95(7):3325-31. doi: 10.1210/jc.2009-2590. Epub 2010 Apr 21. J Clin Endocrinol Metab. 2010. PMID: 20410229 Free PMC article.
References
-
- Arendt J 1995 The pineal gland: basic physiology and clinical implications. In: DeGroot LJ, Besser M, Burger HG, et al., eds. Endocrinology. Vol 1. Philadelphia: WB Saunders; 432–444
-
- Matsumoto M, Sack RL, Blood ML, Lewy AJ 1996 Exogenous melatonin administration does not affect the amplitude of endogenous melatonin production in humans. Sleep Res 25:561
-
- Lewy AJ, Sack RL 1997 Exogenous melatonin’s phase shifting effects on the endogenous melatonin profile in sighted humans: a brief review and critique of the literature. J Biol Rhythms 12:595–603 - PubMed
-
- Lewy AJ, Emens JS, Sack RL, Hasler BP, Bernert RA 2002 Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period. Chronobiol Int 19:649–658 - PubMed
